AVEO logo

AVEO Pharmaceuticals (AVEO) Accounts Payable

Annual Accounts Payable

$2.71 M
-$668.00 K-19.76%

December 31, 2021

Summary

Performance

1-Year Change

-19.76%

3-Year Change

-22.49%

5-Year Change

+11.33%

15-Year Change

+11.33%

AVEO Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$10.63 M
AVEO annual accounts payable is currently -74.48% below its historical high of $10.63 million

3-Year Low

$2.71 M
AVEO annual accounts payable is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
AVEO previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
AVEO next annual earnings announcement has not yet been scheduled

OtherAVEObalance sheetmetrics:

Annual Accounts Receivable

$9.81 M
AVEO annual accounts receivable is $9.81 million

Annual Total Liabilities

$59.47 M
AVEO annual total liabilities is $59.47 million

Annual Total Assets

$105.34 M
AVEO annual total assets is $105.34 million

Annual Current Assets

$104.74 M
AVEO annual total current assets is $104.74 million

Quarterly Accounts Payable

$5.04 M
+$1.43 M+39.78%

September 30, 2022

Summary

Performance

3-Month Change

+39.78%

1-Year Change

+2.31%

3-Year Change

+130.83%

5-Year Change

+159.61%

AVEO Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$12.94 M
AVEO quarterly accounts payable is currently -61.05% below its historical high of $12.94 million

3-Year Low

$2.71 M
AVEO quarterly accounts payable is currently +85.80% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
AVEO previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
AVEO next earnings announcement has not yet been scheduled

OtherAVEObalance sheetmetrics:

Quarterly Accounts Receivable

$18.72 M
AVEO quarterly accounts receivable is $18.72 million

Quarterly Total Liabilities

$72.39 M
AVEO quarterly total liabilities is $72.39 million

Quarterly Total Assets

$101.23 M
AVEO quarterly total assets is $101.23 million

Quarterly Current Assets

$100.73 M
AVEO quarterly total current assets is $100.73 million

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

AVEO Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-19.8%+2.3%
3 y3 years-22.5%+130.8%
5 y5 years+11.3%+159.6%

AVEO Accounts Payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat highat lowat high-46.2%
5 y5-year-19.8%-45.9%at high-70.9%
alltimeall time-74.5%-47.5%-61.1%-94.2%

AVEO Pharmaceuticals Accounts Payable History

DateAnnualQuarterly
Sep 2022
-
$5.04 M(+39.8%)
Jun 2022
-
$3.60 M(+19.6%)
Mar 2022
-
$3.01 M(+11.1%)
Dec 2021
$2.71 M(-19.8%)
$2.71 M(-44.9%)
Sep 2021
-
$4.92 M(+55.8%)
Jun 2021
-
$3.16 M(-20.2%)
Mar 2021
-
$3.96 M(+17.2%)
Dec 2020
$3.38 M(+130.6%)
$3.38 M(+69.1%)
Sep 2020
-
$2.00 M(+12.0%)
Jun 2020
-
$1.78 M(-39.8%)
Mar 2020
-
$2.96 M(+102.3%)
Dec 2019
$1.47 M(-58.1%)
$1.47 M(-32.8%)
Sep 2019
-
$2.18 M(+11.2%)
Jun 2019
-
$1.96 M(-6.9%)
Mar 2019
-
$2.11 M(-39.7%)
Dec 2018
$3.50 M(+43.6%)
$3.50 M(+17.3%)
Sep 2018
-
$2.98 M(+5.7%)
Jun 2018
-
$2.82 M(-16.5%)
Mar 2018
-
$3.38 M(+38.8%)
Dec 2017
$2.44 M(+11.4%)
$2.44 M(+25.5%)
Sep 2017
-
$1.94 M(-42.2%)
Jun 2017
-
$3.36 M(+2.6%)
Mar 2017
-
$3.28 M(+49.9%)
Dec 2016
$2.19 M(+53.4%)
$2.19 M(+85.4%)
Sep 2016
-
$1.18 M(-43.3%)
Jun 2016
-
$2.08 M(+511.5%)
Mar 2016
-
$340.00 K(-76.1%)
DateAnnualQuarterly
Dec 2015
$1.43 M(-56.1%)
$1.43 M(+391.4%)
Sep 2015
-
$290.00 K(-81.5%)
Jun 2015
-
$1.57 M(-40.2%)
Mar 2015
-
$2.62 M(-19.3%)
Dec 2014
$3.25 M(-23.4%)
$3.25 M(+96.2%)
Sep 2014
-
$1.65 M(-52.7%)
Jun 2014
-
$3.50 M(-13.2%)
Mar 2014
-
$4.03 M(-4.9%)
Dec 2013
$4.24 M(-60.1%)
$4.24 M(-30.9%)
Sep 2013
-
$6.14 M(-15.1%)
Jun 2013
-
$7.23 M(-10.6%)
Mar 2013
-
$8.08 M(-23.9%)
Dec 2012
$10.63 M(+19.4%)
$10.63 M(+3.6%)
Sep 2012
-
$10.26 M(+139.9%)
Jun 2012
-
$4.28 M(-43.4%)
Mar 2012
-
$7.55 M(-15.2%)
Dec 2011
$8.90 M(-3.7%)
$8.90 M(-8.0%)
Sep 2011
-
$9.68 M(-25.2%)
Jun 2011
-
$12.94 M(+9.4%)
Mar 2011
-
$11.82 M(+27.9%)
Dec 2010
$9.25 M(+23.4%)
$9.25 M(+5.1%)
Sep 2010
-
$8.80 M(-19.8%)
Jun 2010
-
$10.97 M(+50.2%)
Mar 2010
-
$7.30 M(-2.5%)
Dec 2009
$7.49 M(+94.4%)
$7.49 M(+82.3%)
Sep 2009
-
$4.11 M(+6.6%)
Dec 2008
$3.85 M(+59.4%)
$3.85 M
Dec 2007
$2.42 M
-

FAQ

  • What is AVEO Pharmaceuticals annual accounts payable?
  • What is the all time high annual accounts payable for AVEO Pharmaceuticals?
  • What is AVEO Pharmaceuticals annual accounts payable year-on-year change?
  • What is AVEO Pharmaceuticals quarterly accounts payable?
  • What is the all time high quarterly accounts payable for AVEO Pharmaceuticals?
  • What is AVEO Pharmaceuticals quarterly accounts payable year-on-year change?

What is AVEO Pharmaceuticals annual accounts payable?

The current annual accounts payable of AVEO is $2.71 M

What is the all time high annual accounts payable for AVEO Pharmaceuticals?

AVEO Pharmaceuticals all-time high annual accounts payable is $10.63 M

What is AVEO Pharmaceuticals annual accounts payable year-on-year change?

Over the past year, AVEO annual accounts payable has changed by -$668.00 K (-19.76%)

What is AVEO Pharmaceuticals quarterly accounts payable?

The current quarterly accounts payable of AVEO is $5.04 M

What is the all time high quarterly accounts payable for AVEO Pharmaceuticals?

AVEO Pharmaceuticals all-time high quarterly accounts payable is $12.94 M

What is AVEO Pharmaceuticals quarterly accounts payable year-on-year change?

Over the past year, AVEO quarterly accounts payable has changed by +$114.00 K (+2.31%)